Vivekanand Kattimani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vivekanand Kattimani has a total of 176 co-authors. Here are the top co-authors by number of shared publications:
- Easwaradas Kreedapathy Girija
Department of Physics, Periyar University
6 shared publications - Gnana Sarita Kumari Panga
SIBAR Institute of Dental Sciences, Takkellapadu, Guntur, India
6 shared publications - Rahul Tiwari
Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to Be University)
5 shared publications Krishna Prasad Lingamaneni
Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences, Guntur, India
4 shared publicationsP Srinivas Chakravarthi
Department of Oral and Maxillofacial Surgery, Sibar Institute of Dental Sciences, Andhra Pradesh, India
4 shared publicationsE.K. Girija
2 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in BMC Oral Health
Maxillary sinus pneumatization in healthy dentate individuals: an overview of systematic reviews
Background: Maxillary sinus pneumatization is a dynamic physiological process that alters the anatomical relationship between the sinus floor and posterior maxillary dentition. Excessive pneumatization can reduce alveolar bone height, complicating implant placement and increasing the need for sinus augmentation. Although widely investigated in edentulous and pathological conditions, evidence in healthy, dentate individuals remains limited. Objective: To synthesise evidence from systematic reviews on the development, pneumatization, and volumetric variation of the maxillary sinus in healthy dentate individuals, and to assess the influence of age, gender, ethnicity, and geography. Methods: PubMed, Scopus, and Cochrane databases were searched up to 14 October 2025 using MeSH terms (“maxillary sinus pneumat*,” “maxillary sinus enlarge*,” “maxillary sinus develop*”). Systematic reviews and meta-analyses in dentate populations were included, while studies on pathology, edentulism, or surgical interventions were excluded. Methodological quality was assessed using AMSTAR-2, Glenny, JBI, CASP, and ROBIS tools. Reporting followed PRIOR and PRISMA2020 guidance for overviews. Corrected Covered Area (CCA) analysis was used to assess overlap between reviews. Results: Six systematic reviews were included from 352 records. Overall methodological quality was high (mean compliance 90–93%). Adult sinus volumes ranged from 12–20 cm 3 , with consistent variation by age, gender, and ethnicity. Post-pubertal males exhibited 10–20% larger sinus volumes than females. Across 173 study occurrences (153 unique primary studies), the CCA was 2.6%, indicating minimal overlap. Conclusions: Maxillary sinus morphology demonstrates substantial inter-individual variability driven by developmental and demographic factors. Despite high methodological quality, the current evidence base is largely descriptive and cross-sectional. No review identified definitive causal mechanisms or longitudinal evidence explaining sinus pneumatization, highlighting a critical gap for future research.
- 21 August 2026
- Published by Springer Nature in BMC Oral Health
Open AccessMaxillary sinus pneumatization in healthy dentate individuals: an overview of systematic reviews
Background: Maxillary sinus pneumatization is a dynamic physiological process that alters the anatomical relationship between the sinus floor and posterior maxillary dentition. Excessive pneumatization can reduce alveolar bone height, complicating implant placement and increasing the need for sinus augmentation. Although widely investigated in edentulous and pathological conditions, evidence in healthy, dentate individuals remains limited. Objective: To synthesise evidence from systematic reviews on the development, pneumatization, and volumetric variation of the maxillary sinus in healthy dentate individuals, and to assess the influence of age, gender, ethnicity, and geography. Methods: PubMed, Scopus, and Cochrane databases were searched up to 14 October 2025 using MeSH terms (“maxillary sinus pneumat*,” “maxillary sinus enlarge*,” “maxillary sinus develop*”). Systematic reviews and meta-analyses in dentate populations were included, while studies on pathology, edentulism, or surgical interventions were excluded. Methodological quality was assessed using AMSTAR-2, Glenny, JBI, CASP, and ROBIS tools. Reporting followed PRIOR and PRISMA2020 guidance for overviews. Corrected Covered Area (CCA) analysis was used to assess overlap between reviews. Results: Six systematic reviews were included from 352 records. Overall methodological quality was high (mean compliance 90–93%). Adult sinus volumes ranged from 12–20 cm 3 , with consistent variation by age, gender, and ethnicity. Post-pubertal males exhibited 10–20% larger sinus volumes than females. Across 173 study occurrences (153 unique primary studies), the CCA was 2.6%, indicating minimal overlap. Conclusions: Maxillary sinus morphology demonstrates substantial inter-individual variability driven by developmental and demographic factors. Despite high methodological quality, the current evidence base is largely descriptive and cross-sectional. No review identified definitive causal mechanisms or longitudinal evidence explaining sinus pneumatization, highlighting a critical gap for future research.
- 17 August 2026
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- p. 1-8
Unmasking Maxillofacial Tubercular Osteomyelitis: Diagnostic and Therapeutic Perspectives
- 17 August 2026
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- p. 1-8
Unmasking Maxillofacial Tubercular Osteomyelitis: Diagnostic and Therapeutic Perspectives
- Open Access
- 25 June 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1815447
Eggshell membrane-based biomaterials for tissue regeneration: a systematic review of preclinical evidence
Background: Limitations of conventional wound dressings have spurred the exploration of regenerative biomaterials capable of actively promoting tissue repair. Eggshell membrane (ESM) is emerging as a low-cost, biocompatible scaffold with significant potential in advanced wound care applications. Aim: To evaluate the therapeutic potential of ESM-based wound dressings in enhancing the wound-healing process. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Comprehensive searches were performed across PubMed, Scopus, ScienceDirect, and ProQuest, covering all records up to 22 June 2024. Only English-language studies investigating eggshell membrane as a wound care biomaterial were included. Study selection adhered to predefined eligibility and inclusion criteria. Results: From 599 identified records, 36 studies met the inclusion criteria. Fifteen studies involved in vivo experiments (eight in rats, three in rabbits, three in mice, and one in murine models), with ten also incorporating in vitro analyses. Eight studies were exclusively in vitro . Overall, 15 studies used in vivo methods and 18 utilized in vitro approaches. ESM-based wound dressings consistently demonstrated promising outcomes, accelerating wound repair and tissue regeneration, and often outperforming untreated controls or conventional gauze dressings. A meta-analysis was not feasible due to heterogeneity in study designs, experimental models, and outcome measures. Conclusion: This review highlights the considerable potential of eggshell membrane-based dressings as regenerative biomaterials for the management of complex wounds. While ESM shows strong promise as a scaffold for wound healing, further standardized and clinically focused research is necessary to establish robust evidence supporting its translational and therapeutic applications. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420260551038 , identifier CRD420260551038.
- 25 June 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1815447
Open AccessEggshell membrane-based biomaterials for tissue regeneration: a systematic review of preclinical evidence
Background: Limitations of conventional wound dressings have spurred the exploration of regenerative biomaterials capable of actively promoting tissue repair. Eggshell membrane (ESM) is emerging as a low-cost, biocompatible scaffold with significant potential in advanced wound care applications. Aim: To evaluate the therapeutic potential of ESM-based wound dressings in enhancing the wound-healing process. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Comprehensive searches were performed across PubMed, Scopus, ScienceDirect, and ProQuest, covering all records up to 22 June 2024. Only English-language studies investigating eggshell membrane as a wound care biomaterial were included. Study selection adhered to predefined eligibility and inclusion criteria. Results: From 599 identified records, 36 studies met the inclusion criteria. Fifteen studies involved in vivo experiments (eight in rats, three in rabbits, three in mice, and one in murine models), with ten also incorporating in vitro analyses. Eight studies were exclusively in vitro . Overall, 15 studies used in vivo methods and 18 utilized in vitro approaches. ESM-based wound dressings consistently demonstrated promising outcomes, accelerating wound repair and tissue regeneration, and often outperforming untreated controls or conventional gauze dressings. A meta-analysis was not feasible due to heterogeneity in study designs, experimental models, and outcome measures. Conclusion: This review highlights the considerable potential of eggshell membrane-based dressings as regenerative biomaterials for the management of complex wounds. While ESM shows strong promise as a scaffold for wound healing, further standardized and clinically focused research is necessary to establish robust evidence supporting its translational and therapeutic applications. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420260551038 , identifier CRD420260551038.
- 5 June 2026
- Published by Elsevier
- p. 87-123
Separation technologies of eggshell and eggshell membrane
- 5 June 2026
- Published by Elsevier
Contributors
- Open Access
- 30 December 2025
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16 (1) , 260-266
Evaluating the efficacy of eggshell-derived hydroxyapatite (EHA) and synthetic hydroxyapatite (SHA) in bone regeneration of maxillofacial defects-a randomized double-blind pilot comparative clinical-radiological study
- 30 December 2025
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16 (1) , 260-266
Open AccessEvaluating the efficacy of eggshell-derived hydroxyapatite (EHA) and synthetic hydroxyapatite (SHA) in bone regeneration of maxillofacial defects-a randomized double-blind pilot comparative clinical-radiological study
- 15 January 2025
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 24 (4) , 1075-1089
Patient-Specific Implants in Maxillo-Facial Reconstruction: Current Practices and Way Forward—An Overview of Systematic Reviews
Background Maxillofacial reconstruction has undergone a paradigm shift from conventional to digital workflows. The integration of Three Dimensional (3D) technology and patient-specific implants (PSIs) has revolutionized surgical planning and execution, particularly in complex procedures. This overview of systematic review (SR) aims to provide healthcare professionals with a comprehensive, evidence-based resource on current practices and future perspectives of maxillofacial reconstruction using 3D technology and PSIs. Methods A comprehensive literature search was conducted from inception 30th September 2023, using keywords such as “3D printing,” “patient-specific implants,” “maxillofacial reconstruction,” and related terms. The search included PubMed, ScienceDirect, and Cochrane databases. Only SRs focusing on maxillofacial reconstruction with 3D technology were included. Article quality was assessed using the AMSTAR (A MeaSurement Tool to Assess systematic Reviews) tool and Glenny et al. checklists. Results Out of 327 search results, fourteen articles met the inclusion criteria. Most reviews focused on reconstructing orbital, nasal, maxillary, mandibular, and temporomandibular joint defects. Notably, only one Cochrane review was identified, indicating a lack of high-quality randomized or cohort studies. Furthermore, only three reviews had a registered protocol. Conclusion While the literature supports the use of PSIs and 3D technology in maxillofacial reconstruction, the evidence quality remains moderate to poor. The heterogeneity of the data across studies has limited the ability to perform a meta-analysis. SRs emphasize the need for careful ethical considerations when using medical devices like PSIs. Although advanced technologies enhance surgical outcomes, they come with a steep learning curve and require rigorous clinical validation.
- 15 January 2025
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
- Vol. 24 (4) , 1075-1089
Patient-Specific Implants in Maxillo-Facial Reconstruction: Current Practices and Way Forward—An Overview of Systematic Reviews
Background Maxillofacial reconstruction has undergone a paradigm shift from conventional to digital workflows. The integration of Three Dimensional (3D) technology and patient-specific implants (PSIs) has revolutionized surgical planning and execution, particularly in complex procedures. This overview of systematic review (SR) aims to provide healthcare professionals with a comprehensive, evidence-based resource on current practices and future perspectives of maxillofacial reconstruction using 3D technology and PSIs. Methods A comprehensive literature search was conducted from inception 30th September 2023, using keywords such as “3D printing,” “patient-specific implants,” “maxillofacial reconstruction,” and related terms. The search included PubMed, ScienceDirect, and Cochrane databases. Only SRs focusing on maxillofacial reconstruction with 3D technology were included. Article quality was assessed using the AMSTAR (A MeaSurement Tool to Assess systematic Reviews) tool and Glenny et al. checklists. Results Out of 327 search results, fourteen articles met the inclusion criteria. Most reviews focused on reconstructing orbital, nasal, maxillary, mandibular, and temporomandibular joint defects. Notably, only one Cochrane review was identified, indicating a lack of high-quality randomized or cohort studies. Furthermore, only three reviews had a registered protocol. Conclusion While the literature supports the use of PSIs and 3D technology in maxillofacial reconstruction, the evidence quality remains moderate to poor. The heterogeneity of the data across studies has limited the ability to perform a meta-analysis. SRs emphasize the need for careful ethical considerations when using medical devices like PSIs. Although advanced technologies enhance surgical outcomes, they come with a steep learning curve and require rigorous clinical validation.
- 21 June 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review
Introduction Nanotechnology has shown potential in treating diferent types of cancers. In particular, nano-drug delivery systems (DDSs) ofer a promising strategy for treating oral cancer. By customizing therapy and improving drug delivery, these systems can improve outcomes for patients. Hence, a review was conducted to assess the current evidence and explore the use of DDSs for treating oral cancer. Aim To comprehensively explore the nano-drug carriers and target delivery for oral cancer therapy and to discuss the benefits, challenges, and potential to guide future research and clinical practice. Methodology A systematic search of articles archived in PubMed, Scopus, and Cochrane using keywords such as Nano, drug carrier, target drug delivery, and oral cancer was performed to fulfll the objectives from inception till February 2, 2024. Articles providing insights into nano-drug carriers in oral cancer were included. Results The results revealed a total of 156 articles. After duplicate removal, 136 articles were screened for title and abstract as per the inclusion and exclusion criteria. A total of 113 articles were excluded with reasons. Out of the remaining 23 articles, only 11 were included for qualitative data synthesis. Conclusion The literature revealed scarcity of oral cancer-related work using DDSs. Qualitative synthesis of data revealed that nano-drug carriers demonstrated a promising avenue for targeted therapeutic approaches in oral cancer, despite the challenges and their potential benefts. Continued research and development in this field are crucial to overcoming these challenges and fully realizing the potential of nano-drug carriers in revolutionizing oral cancer therapy. Keywords Chemotherapy · Drug delivery · Management · Nanotechnology · Tumor
- 21 June 2024
- Published by Springer Nature in Journal of Maxillofacial and Oral Surgery
Nano-Drug Carriers for Targeted Therapeutic Approaches in Oral Cancer: A Systematic Review
Introduction Nanotechnology has shown potential in treating diferent types of cancers. In particular, nano-drug delivery systems (DDSs) ofer a promising strategy for treating oral cancer. By customizing therapy and improving drug delivery, these systems can improve outcomes for patients. Hence, a review was conducted to assess the current evidence and explore the use of DDSs for treating oral cancer. Aim To comprehensively explore the nano-drug carriers and target delivery for oral cancer therapy and to discuss the benefits, challenges, and potential to guide future research and clinical practice. Methodology A systematic search of articles archived in PubMed, Scopus, and Cochrane using keywords such as Nano, drug carrier, target drug delivery, and oral cancer was performed to fulfll the objectives from inception till February 2, 2024. Articles providing insights into nano-drug carriers in oral cancer were included. Results The results revealed a total of 156 articles. After duplicate removal, 136 articles were screened for title and abstract as per the inclusion and exclusion criteria. A total of 113 articles were excluded with reasons. Out of the remaining 23 articles, only 11 were included for qualitative data synthesis. Conclusion The literature revealed scarcity of oral cancer-related work using DDSs. Qualitative synthesis of data revealed that nano-drug carriers demonstrated a promising avenue for targeted therapeutic approaches in oral cancer, despite the challenges and their potential benefts. Continued research and development in this field are crucial to overcoming these challenges and fully realizing the potential of nano-drug carriers in revolutionizing oral cancer therapy. Keywords Chemotherapy · Drug delivery · Management · Nanotechnology · Tumor